JEGI LEONIS a conseillé Forge, une société du portefeuille d'Apollo, dans le cadre de son accord définitif en vue de l'acquisition de Becker's Healthcare, une société du portefeuille de Pamlico Capital

Apollo portfolio company Forge agreed to acquire Becker's Healthcare from Pamlico Capital, expanding its healthcare and life-sciences media and events footprint. Becker's reaches more than 1.5 million healthcare executives and hosts over 15,000 annual in-person event attendees; combined with Forge's Fierce Healthcare and Life Sciences business, the platform will operate more than 35 live events. The deal supports Forge's strategy of consolidating B2B media assets in structurally growing healthcare markets, though financial terms were not disclosed.

Analysis

This is strategically coherent but financially immaterial for APO shareholders absent purchase price, leverage and pro forma EBITDA disclosure. The relevant value creation is not audience aggregation alone; it is whether Forge can raise revenue per healthcare executive through bundled sponsorships, data products and cross-sold events while consolidating overlapping editorial, sales and event infrastructure. Healthcare-focused B2B media has relatively resilient advertiser demand versus broad digital media, but event revenue remains cyclical and sensitive to hospital capital-spending budgets, pharma marketing intensity and travel restrictions.

Over the next 1-3 months, the transaction is more useful as evidence that Apollo is pursuing a roll-up model in fragmented vertical media than as an APO earnings catalyst. The principal risk is multiple expansion being paid upfront for assets whose revenue is dependent on annual conference attendance and sponsor renewals; aggressive leverage at Forge would limit Apollo's ability to extract value through a later exit. Over 6-18 months, successful integration could make Forge a credible strategic asset for larger information-services buyers such as RELX, Informa or Clarivate, but a weak 2027 event-booking cycle would expose the lower-quality, cyclical portion of the platform.

The contrarian view is that the combination may reduce rather than increase monetization if hospital executives perceive the merged platform as less independent or if sponsors shift budgets toward account-based digital marketing and proprietary customer events. The absence of disclosed consideration, retention metrics, recurring-revenue mix and net-debt financing means the press release does not yet support underwriting an accretive return for APO.

Key Decisions for Investors

• No standalone APO trade on this announcement; treat it as a watch item. Reassess only if Apollo discloses Forge valuation, debt financing and expected EBITDA/cost synergies. A transaction financed with materially higher leverage than comparable B2B-information platforms would be a negative read-through for exit optionality.
• Monitor APO's next earnings call for aggregate-fee-related earnings exposure, balance-sheet capital committed to Forge, and commentary on realization timing. The thesis becomes constructive if management demonstrates limited incremental capital at risk and a clear path to a strategic exit within 3-5 years; it is falsified by higher-than-expected principal-investing commitments or integration charges.
• Do not use EEX as a public-market proxy without confirming its current listing and float status following Apollo's acquisition. If EEX remains publicly tradable, any persistent discount to the announced acquisition consideration is an event-driven spread-monitoring opportunity, not a fundamental healthcare-media trade.